View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Novo Nordisk Pharmatech
13 September 2016

Novo Nordisk Pharmatech to Attend CHPI Worldwide in Barcelona

Novo Nodisk QUATS

Novo Nordisk Pharmatech has announced it will be attending CHPI Worldwide to showcase its product portfolio.

The company is a leading supplier of crystalline quaternary ammonium compounds (QUATS) for a wide range of applications due to its innovative synthesis process.

QUATS such as current good manufacturing practice (cGMP) Benzalkonium Chloride, Cetrimide, and Cetyl trimethylammonium bromide (CTAB) have excellent antimicrobial and surface-active properties. They are also active against the most common micro-organisms, such as bacteria, fungi, and algae.

Novo Nordisk’s QUATS have high-levels of purity, which make them particularly suited for pharmaceutical applications, such as vaccine production. They act either as preservatives or active ingredients in many ophthalmic, nasal, oral and topical drugs and in a variety of solutions, ointments and creams.

CPHI Worldwide will take place in Fira de Barcelona Gran Via from 4 October to 6 October. Novo Nordisk will be presenting in Hall 4, stand 5B1.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology